Related Experiment Video
Updated: Jun 22, 2025
09:52
An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy
Published on: April 21, 2014
19.7K
Does 5-ALA Fluorescence Microscopy Improve Complete Resectability in Cerebral/Cerebellar Metastatic Surgery? A
Hraq Mourad Sarkis1,2,3, Samer Zawy Alsofy1,2, Ralf Stroop1
1Department of Medicine, Faculty of Health, Witten/Herdecke University, 58448 Witten, Germany.
Cancers
|June 27, 2024
Summary
5-aminolevulinic acid (5-ALA) fluorescence aids in brain tumor surgery. This method improves complete tumor resection rates and significantly increases patient survival times, offering a low-risk surgical enhancement.
Area of Science:
- Neurosurgery
- Oncology
- Medical Imaging
Background:
- Analysis of intraoperative fluorescence in brain metastases post-5-aminolevulinic acid (5-ALA) administration.
- Investigating the impact of 5-ALA fluorescence-guided resection on completeness of resection and survival outcomes.
Purpose of the Study:
- To determine if 5-ALA fluorescence-guided resection of brain metastases leads to more complete tumor removal.
- To assess the correlation between 5-ALA fluorescence and improved patient survival.
Main Methods:
- Retrospective analysis of patient data including age, sex, metastasis characteristics, and survival time.
- Intraoperative fluorescence assessment and postoperative MRI for evaluating resection completeness.
- Statistical analysis to correlate fluorescence with resection extent and survival.
Main Results:
- Brain metastases exhibited fluorescence in 57.5% of cases, with higher rates in breast carcinoma (73.3%).
- Complete resection was achieved in 82.5% of patients; 56.1% of these were fluorescence-positive.
- Fluorescence-positive cases showed a trend towards improved resectability and significantly longer survival (p=0.009).
Conclusions:
- 5-ALA-assisted surgery enhances the completeness of brain metastases resection.
- This technique is associated with significantly longer survival times for patients.
- 5-ALA fluorescence represents a valuable, low-risk adjunct for modern brain metastasis surgery.
